New tests have been added on the Request Form for monitoring of biopharmaceuticals for Therapeutic Drug Monitoring (TDM)

June 4, 2018 - Company News, Product News
New tests have been added on the Request Form for monitoring of biopharmaceuticals for Therapeutic Drug Monitoring (TDM)

NEW tests:
Biopharmaceutical drugs

Monitoring of drug concentration and Anti-Drug Antibodies (ADA):

Monitoring of drug concentration:

The Biopharmaceutical drugs already offered in our portfolio: 

Monitoring of drug concentration and Anti-Drug Antibodies (ADA) or Neutralising Anti-Drug Antibodies (Nabs):

All TNF-alpha inhibitors

Monitoring of drug concentration and Anti-Drug Antibodies (ADA):

ADA (Anti-Drug Antibodies):

Neutralising Anti-Drug Antibodies (Nabs):

Updated Request Forms

The Request Forms has been updated with the changes stated above.

For more information please contact:

Diagnostic.services@wieslab.com
Lab Manager, Rita Martins Olofsson: + 46 40 - 643 44 12
Key Account Manager, Monica Blixt: +46 708 86 28 10
The Laboratory: +46 40 - 53 76 60

Click the links for more information regarding:

Sampling instructions
Request Forms
Opening hours
Terms and Conditions